Altruist Biologics Congratulates Partner LongBio Pharma on the BLA Acceptance of LP-003 by the China NMPA
- Written by PR Newswire
![]() |
- Enabled by Altruist's integrated CMC development platform, GMP manufacturing and regulatory service capabilities, LP-003 has successfully advanced from concept to potential commercialization.
- LP-003 is the first innovative drug independently developed by LongBio Pharma to advance to BLA submission.
HANGZHOU, China, Sept. 14, 2026 /PRNewswire/ --...















